After gaining 58% over the past year, Rocket Lab USA (NASDAQ: RKLB) now faces a critical test as volatile trading raises questions about where the stock finishes 2026.
RKLB currently trades at $70.43, and a proprietary model from 24/7 Wall St. puts the year-end price target at $81.63, implying roughly 15.9% upside from current levels.
The recommendation is a buy, though analysts assign only a 50% confidence level given the stock’s elevated volatility and recent price swings.
Shares surged as high as $124.77 in mid-May before cratering nearly 30% over the following month, even as no significant negative news emerged to justify the selloff.
The stock sits roughly 24% below its 52-week high of $151 but remains well above its 52-week low of $37.57, reflecting just how wide the trading range has been this year.
A Reddit thread on r/wallstreetbets titled “RKLB down 35% in a month on zero bad news, generational buying opportunity or are we the exit liquidity?” attracted more than 1,100 upvotes, capturing the divided sentiment among retail investors.
Fundamentals have remained strong through the turbulence, with Q1 FY26 revenue hitting $200.35 million, a 63.5% year-over-year gain that beat consensus estimates by 5.77%.
Non-GAAP gross margin expanded to 43% from 33.4% in the prior year period, while backlog reached a record $2.20 billion, supporting Q2 revenue guidance of $225 million to $240 million.
CEO Peter Beck confirmed the company’s selection for the Department of Defense’s Space Based Interceptor program under Golden Dome for America, in partnership with Raytheon.
Rocket Lab also signed 31 new Electron and HASTE launch agreements plus five Neutron missions in Q1 alone, adding to the $816 million SDA Tranche 3 contract, the largest in company history.
The Neutron medium-lift rocket is targeting a debut launch later in 2026, and a successful first flight would position it as a direct competitive alternative to SpaceX’s Falcon 9.
The bull case takes RKLB to $95.07 by December, supported by a launch manifest already exceeding 70 contracted missions and Wall Street analyst ratings showing 3 Strong Buys and 11 Buys against just 3 Holds.
Bears point to persistent cash burn, with FY25 delivering a net loss of $198.2 million on $601.8 million in revenue, while Q1 FY26 required $450 million raised through an at-the-market equity offering.
Neutron has already slipped once after a stage-1 tank test failure pushed the debut to Q4 2026, and any further delay would likely rattle investor confidence in the program.
Polymarket data shows only a 34.5% probability that RKLB beats its next quarterly earnings report, and insider activity has skewed toward net selling across 91 recent transactions.
The bear case lands at $77.83 by year-end, with dilution reflecting a deliberate capital build-out ahead of expected Neutron and Golden Dome revenues coming online.
Compared to AST SpaceMobile (NASDAQ: ASTS), which posted just $14.73 million in Q1 2026 revenue against a $17.5 billion market cap, RKLB’s $679.6 million in trailing revenue looks far more substantial relative to its $40.6 billion valuation.
Planet Labs (NYSE: PL) offers a closer commercial comparison, guiding FY27 revenue of $425 million to $441 million with backlog above $906 million and a $7.17 billion market cap.
RKLB commands roughly five times Planet’s market cap on a comparable growth trajectory but carries Neutron optionality and a larger backlog that arguably justifies the premium on a growth-adjusted basis.
Longer-term projections from 24/7 Wall St. put RKLB at $124.43 in 2027, $178 in 2028, $245 in 2029, and $331.69 in 2030, assuming execution on Neutron, Golden Dome, and SDA satellite constellation programs holds.
